How the new Alzheimer’s disease drug could influence future research
Published
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
Full ArticlePublished
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
Full Articlehttps://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since..